Neuroscience
Glutamic Acid
100%
Levetiracetam
66%
Memantine
66%
Aspartic Acid
66%
NMDA Receptor Antagonist
66%
Neuronal Depolarization
33%
In Vivo
33%
Reuptake
33%
Nerve Tissue
33%
Cleft
33%
Brain Slice
33%
Neurotransmitter
33%
Behavior (Neuroscience)
33%
Isocitrate Dehydrogenase 2
33%
In Vitro
33%
Nerve Cell Membrane
33%
Multielectrode Array
33%
Isocitrate Dehydrogenase 1
33%
Oxidative Stress
33%
Receptor down Regulation
33%
Membrane Depolarization
33%
NMDA Receptor
33%
Patch Clamp
33%
Alzheimer's Disease
33%
Enzyme Inhibitor
33%
Receptor
33%
Intracranial Tumor
33%
Anticonvulsant
33%
Mouse Brain
33%
Keyphrases
Glioma
100%
2-Hydroxyglutarate (2-HG)
90%
Seizure
70%
Tumor-related Epilepsy
30%
N-methyl-D-aspartate Receptor (NMDAR)
30%
Levetiracetam
20%
Memantine
20%
Neuronal Network Activity
20%
Glutamate
20%
Non-neoplastic
20%
Keppra
10%
Glutamate Reuptake
10%
Frontline Treatment
10%
Antiseizure Effect
10%
Hippocampal Damage
10%
Receptor Downregulation
10%
AG-120
10%
Mouse Cortical Neurons
10%
World Health Organization Grade
10%
AG-881
10%
Synaptic Cleft
10%
Repeated Seizures
10%
Seizure Activity
10%
Oxidative Stress
10%
Targeted Therapeutics
10%
Isocitrate Dehydrogenase 1 (IDH1)
10%
Mouse Behavior
10%
Monotherapy
10%
Neuronal Depolarization
10%
Clinical Trials
10%
Neural Tissue
10%
Multielectrode Array
10%
Patch Clamp
10%
Patient Experience
10%
Successful Completion
10%
Neuronal Loss
10%
Neuronal Membrane
10%
Alzheimer's Disease
10%
Excitatory Neurotransmission
10%
NMDA Receptor Antagonist
10%
Increased Incidence
10%
Glioma Patients
10%
Mouse Brain Slices
10%
Primary Brain Tumor
10%
Electrical Activity
10%
Epilepsy
10%
Antiepileptic Drugs
10%
Infiltrative Glioma
10%
Membrane Depolarization
10%
Enzyme Inhibitors
10%
Pathologic
10%
Inflammation
10%
Patient-derived
10%
N-methyl-D-aspartate Receptor Antagonist
10%
Glioblastoma
10%